Table 1. HERG1 protein expression and clinic- pathological features of pancreatic tumors.
| clinico-pathological features | HERG1 expression (positive/total number of analyzed samples) | P | |
|---|---|---|---|
| Sex | male | 44/49 | 0.621 |
| female | 27/29 | ||
| Age (y) | ≥65 | 36/41 | 0.295 |
| <65 | 35/37 | ||
| Lymph node metastasis | + | 59/62 | 0.012 |
| − | 12/16 | ||
| TNM stage | I | 3/6 | 0.008 |
| II | 68/72 | ||
| Differentiation | 1. poor | 41/41 | 1 vs. 3 0.000 |
| 2. moderate | 27/30 | 2 vs. 3 0.004 | |
| 3. well | 3/7 | 1+2 vs. 3 0.001 | |
P< 0.05 was considered as statistically significant.